Rozanolixizumab Reaches a Broad Real-World Myasthenia Gravis Population in the USA
A retrospective cohort study of 877 US adults found that rozanolixizumab has been initiated in a broad myasthenia gravis population, ...
A retrospective cohort study of 877 US adults found that rozanolixizumab has been initiated in a broad myasthenia gravis population, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.